Zurueck zur Suche

Reporte zur Charge U012525

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 1 NJ 1 MI 1

VAERS 2290222

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012525

mild
Staat
IL
Alter
-
Geschlecht
F
Eingang
23.05.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Malaise Product administered to patient of inappropriate age Underdose

Symptomtext

the patient is "not feeling the best today" as she received multiple vaccines yesterday; adult patient was administered a pediatric dose of VAQTA yesterday, 21-APR-2022; adult patient was administered a pediatric dose of VAQTA yesterday, 21-APR-2022; This spontaneous report has been received from a registered nurse and refers to an adult female patient. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported. On 21-APR-2022, the adult patient was administered a 0.5 milliliters (ml) pediatric dose of hepatitis a vaccine, inactivated (VAQTA) for hepatitis A prophylaxis (valid lot number U012525 for vial formulation, with expiration date 06-FEB-2023) (product administered to patient of inappropriate age and underdose). On the same date, the patient received varicella zoster vaccine rge (cho) (SHINGRIX) and unspecified rabies and typhoid vaccines (formulation, dose, indication, lot number, and expiration date were not reported). The dose number, vaccination scheme, route of administration, and anatomical location were not provided for any of the suspect vaccines. On 22-APR-2022, the patient was not feeling the best (malaise), unresolved by reporting time. The nurse reported that the patient was not feeling the best as she received multiple vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2316237

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012525

gering
Staat
NJ
Alter
0,2
Geschlecht
U
Eingang
11.06.2022
Impfdatum
26.05.2022
Beginn
26.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE reported; a 2 month old patient was inadvertently administered a pediatric dose of VAQTA on 26 MAY 2022; This spontaneous report has been received from a Registered Nurse, referring to a 2-month-old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided. On 26-MAY-2022, the patient was inadvertently vaccinated with a pediatric dose of hepatitis A vaccine, inactivated (VAQTA) intramuscular Injection, at a dose of 0.5 milliliter (ml) as prophylaxis (route of administration, vaccination scheme frequency, and anatomical location were not reported); lot number U012525 has been verified to be a valid lot number for hepatitis A vaccine, inactivated (VAQTA) vial formulation, expiration date reported and upon internal validation established as 06-FEB-2023) (product administered to patient of inappropriate age). Besides, no adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2272990

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012525

gering
Staat
MI
Alter
57,0
Geschlecht
F
Eingang
12.05.2022
Impfdatum
31.03.2022
Beginn
31.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

No additional AE reported; HCP reported that a adult patient received a pediatric dose of VAQTA. No additional AE reported. No PQC reported. No further information was provided.; This spontaneous report was received from healthcare professional (HCP) and refers to a 57-year-old female patient. Information regarding the patient's historical conditions, past drugs reactions or allergies, concurrent conditions or concomitant therapies was not provided. /was unknown by the reporter. On 31-MAR-2022, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) injection at a dose of 0.5 milliliters (mL) (incorrect dose administered) administered for prophylaxis (lot #U012525 verified as valid, expiration date reported and stablished as 06-FEB-2023) (strength, and route of administration were not provided). No additional adverse events (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-